Mindray Medical co-founder takes up new role
This article was originally published in Clinica
Minghe Cheng has become chief strategic officer at Mindray Medical International, the company he co-founded. Mr Minghe will deal with the Chinese firm’s business model development, short- and long-term strategic programme planning and corporate structure optimisation. He has worked for Mindray in various roles across its sales, marketing and strategic development departments for 17 years. The Shenzhen-based firm specialises in manufacturing medical devices in the fields of in vitro diagnostics, patient monitoring and imaging.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals